Aiyar Ram 4

What Happened Aiyar Ram, President, CEO and Director of Korro Bio, was granted a total of 120,000 equity awards on February 2, 2026: 40,000 restricted stock units (RSUs) and 80,000 derivative equity units (option-like award). Both grants show an acquisition price of $0.00, so no cash was paid for these awards on grant. This is a compensatory equity grant to an insider rather than a market purchase or sale.

Key Details

• Transaction date: 2026-02-02; filing date: 2026-02-03 (Form 4 filed timely).
• Grants: 40,000 RSUs @ $0.00; 80,000 derivative units @ $0.00 (total 120,000).
• Vesting: RSUs (F1) vest 50% on Aug 3, 2026 and 50% on Feb 1, 2027, subject to continued service. Derivative units (F3) vest in 48 equal monthly installments beginning Feb 2, 2026, subject to continued service.
• Footnote F2: separate shares are held by The Ram Aiyar Irrevocable Trust; the reporting person disclaims beneficial ownership of those trust-held shares except to the extent of pecuniary interest.
• Shares owned after the transaction are not specified in the supplied summary of the filing.

Context These grants are standard executive compensation awards (RSUs and a time-vesting derivative equity award). RSUs convert to shares upon vesting (no exercise required); the derivative award vests monthly over four years. Such grants are not sales or purchases in the open market and should be viewed as compensation rather than a direct bullish/bearish trading signal.